The Inquiry - Why drug firms don鈥檛 invest more in curing early stage cancer - 麻豆社 Sounds

The Inquiry - Why drug firms don鈥檛 invest more in curing early stage cancer - 麻豆社 Sounds

The Inquiry
Why drug firms don鈥檛 invest more in curing early stage cancer
Available for over a year

MIT Economics Professor Heidi Williams studied the treatments that got the most funding.

More episodes
Programme Website

Coming Up Next